The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

(2018) Cristina Mussini et al.   BMC Medicine

Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients

(2018) Barbara Rossetti et al.   EXPERT OPINION ON PHARMACOTHERAPY

Similar long-term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV-1-infected patients in a retrospective, real-life cohort of 14 years

(2018) I Krznaric et al.   HIV MEDICINE

New Strategies of ARV: the Road to Simplification

(2018) Rosa de Miguel Buckley et al.   Current HIV/AIDS Reports

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

(2018) Pedro Cahn et al.   LANCET

Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study

(2017) Pedro Cahn et al.   Journal of the International AIDS Society

Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?

(2017) Joseph A. McBride et al.   PLoS Pathogens

A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV

(2017) Matthew Triplette et al.   PLoS One

Muertes por enfermedades no asociadas directamente con el sida en pacientes con infección por el VIH: un estudio de 14 años (1998-2011)

(2016) Cristina López et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study

(2016) Mariam Noelie Hema et al.   PLoS One

Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database

(2015) Gaetana Sterrantino et al.   INFECTION

CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

(2015) Cristina Mussini et al.   Lancet HIV

Aging of the human innate immune system in HIV infection

(2014) Heidi J Zapata et al.   CURRENT OPINION IN IMMUNOLOGY

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

(2014) Colette J Smith et al.   LANCET

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

(2014) Pedro Cahn et al.   LANCET INFECTIOUS DISEASES

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

(2014) Sergio Serrano-Villar et al.   PLoS Pathogens

Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs

(2011) Jean Nachega et al.   Patient Preference and Adherence